156 related articles for article (PubMed ID: 32406758)
1. Inhibition of CYP2C9 by natural products: insight into the potential risk of herb-drug interactions.
Wang K; Gao Q; Zhang T; Rao J; Ding L; Qiu F
Drug Metab Rev; 2020 May; 52(2):235-257. PubMed ID: 32406758
[TBL] [Abstract][Full Text] [Related]
2. In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica.
Pan Y; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Pook PC; Er HM; Ong CE
J Ethnopharmacol; 2010 Jul; 130(2):275-83. PubMed ID: 20457244
[TBL] [Abstract][Full Text] [Related]
3. Modulation of CYP3A4 and CYP2C9 activity by Bulbine natalensis and its constituents: An assessment of HDI risk of B. natalensis containing supplements.
Husain I; Manda V; Alhusban M; Dale OR; Bae JY; Avula B; Gurley BJ; Chittiboyina AG; Khan IA; Khan SI
Phytomedicine; 2021 Jan; 81():153416. PubMed ID: 33321412
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory activity of the extracts of popular medicinal herbs on CYP1A2, 2C9, 2C19 and 3A4 and the implications for herb-drug interaction.
Fasinu PS; Bouic PJ; Rosenkranz B
Afr J Tradit Complement Altern Med; 2014; 11(4):54-61. PubMed ID: 25392581
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cytochrome P450 2C9 expression and activity in vitro by allyl isothiocyanate.
Lim YP; Chen WC; Cheng CH; Ma WC; Lin YH; Chen CY; Hung DZ; Chen JJ; Yokoi T; Nakajima M; Chen CJ
Planta Med; 2014 Aug; 80(13):1097-106. PubMed ID: 25197954
[TBL] [Abstract][Full Text] [Related]
6. Effect of 95% Ethanol Khat Extract and Cathinone on in vitro Human Recombinant Cytochrome P450 (CYP) 2C9, CYP2D6, and CYP3A4 Activity.
Lim SYM; Binti Azidin AR; Ung YT; Al-Shagga M; Alshawsh MA; Mohamed Z; Ong CE; Pan Y
Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):423-431. PubMed ID: 30306496
[TBL] [Abstract][Full Text] [Related]
7. The in-vitro effect of complementary and alternative medicines on cytochrome P450 2C9 activity.
Mooiman KD; Goey AK; Huijbregts TJ; Maas-Bakker RF; Beijnen JH; Schellens JH; Meijerman I
J Pharm Pharmacol; 2014 Sep; 66(9):1339-46. PubMed ID: 24730468
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic study of bergamottin-induced inactivation of CYP2C9.
Liu Y; Zhang S; Jiang T; Tan R; Fu Y; Yang X; Gong B; Zou Y; Li W; Zheng J
Food Chem Toxicol; 2021 Jul; 153():112278. PubMed ID: 34019943
[TBL] [Abstract][Full Text] [Related]
9. Interactions of herbs with cytochrome P450.
Zhou S; Gao Y; Jiang W; Huang M; Xu A; Paxton JW
Drug Metab Rev; 2003 Feb; 35(1):35-98. PubMed ID: 12635815
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 2C9-natural antiarthritic interactions: Evaluation of inhibition magnitude and prediction from in vitro data.
Tan BH; Ahemad N; Pan Y; Palanisamy UD; Othman I; Yiap BC; Ong CE
Biopharm Drug Dispos; 2018 Apr; 39(4):205-217. PubMed ID: 29488228
[TBL] [Abstract][Full Text] [Related]
11. Mechanism-based inactivation of cytochrome P450 enzymes by natural products based on metabolic activation.
Zhang T; Rao J; Li W; Wang K; Qiu F
Drug Metab Rev; 2020 Nov; 52(4):501-530. PubMed ID: 33043714
[TBL] [Abstract][Full Text] [Related]
12. Different inhibitory effects of azole-containing drugs and pesticides on CYP2C9 polymorphic forms: An in vitro study.
Haidukevich IV; Sushko TA; Tumilovich AM; Grabovec IP; Usanov SA; Gilep AA
Toxicol In Vitro; 2018 Aug; 50():249-256. PubMed ID: 29621561
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of curcumin on activity of cytochrome P450 2C9 enzyme in human and 2C11 in rat liver microsomes.
Wang Z; Sun W; Huang CK; Wang L; Xia MM; Cui X; Hu GX; Wang ZS
Drug Dev Ind Pharm; 2015 Apr; 41(4):613-6. PubMed ID: 24517573
[TBL] [Abstract][Full Text] [Related]
14. In vivo pharmacokinetic interaction by ethanolic extract of Gymnema sylvestre with CYP2C9 (Tolbutamide), CYP3A4 (Amlodipine) and CYP1A2 (Phenacetin) in rats.
Vaghela M; Sahu N; Kharkar P; Pandita N
Chem Biol Interact; 2017 Dec; 278():141-151. PubMed ID: 29042257
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Cytochrome P450, P-glycoprotein and Pregnane X Receptor by Selected Antimalarial Herbs-Implication for Herb-Drug Interaction.
Fasinu PS; Manda VK; Dale OR; Egiebor NO; Walker LA; Khan SI
Molecules; 2017 Nov; 22(12):. PubMed ID: 29168799
[TBL] [Abstract][Full Text] [Related]
16. Ginkgo biloba: evaluation of CYP2C9 drug interactions in vitro and in vivo.
Mohutsky MA; Anderson GD; Miller JW; Elmer GW
Am J Ther; 2006; 13(1):24-31. PubMed ID: 16428919
[TBL] [Abstract][Full Text] [Related]
17. Potent inhibitory effect of alpha-viniferin on human cytochrome P450.
Sim J; Jang HW; Song M; Kim JH; Lee SH; Lee S
Food Chem Toxicol; 2014 Jul; 69():276-80. PubMed ID: 24769006
[TBL] [Abstract][Full Text] [Related]
18. Involvement of CYP2C9 and UGT2B7 in the metabolism of zaltoprofen, a nonsteroidal anti-inflammatory drug, and its lack of clinically significant CYP inhibition potential.
Furuta S; Akagawa N; Kamada E; Hiyama A; Kawabata Y; Kowata N; Inaba A; Matthews A; Hall M; Kurimoto T
Br J Clin Pharmacol; 2002 Sep; 54(3):295-303. PubMed ID: 12236850
[TBL] [Abstract][Full Text] [Related]
19. Interaction of quercetin and its metabolites with warfarin: Displacement of warfarin from serum albumin and inhibition of CYP2C9 enzyme.
Poór M; Boda G; Needs PW; Kroon PA; Lemli B; Bencsik T
Biomed Pharmacother; 2017 Apr; 88():574-581. PubMed ID: 28135601
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids.
Salminen KA; Meyer A; Jerabkova L; Korhonen LE; Rahnasto M; Juvonen RO; Imming P; Raunio H
Phytomedicine; 2011 Apr; 18(6):533-8. PubMed ID: 20851588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
